158 related articles for article (PubMed ID: 28133294)
1. [A Case of Rectal Cancer with Unresectable Liver Metastasis Responding to Rechallenge with FOLFIRI].
Kamiya M; Yoneyama K; Doi Y; Shirai J; Suzuki Y; Hatori S; Yamada T; Sato T; Yamamoto N; Oshima T; Yukawa N; Yoshikawa T; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2277-2279. PubMed ID: 28133294
[TBL] [Abstract][Full Text] [Related]
2. [A Case of a Patient with Rectum Cancer with Multiple Metastases, Who Was Able to Undergo Conversion Therapy Using Alternating mFOLFOX6 and FOLFIRI Regimens in Combination with Alternating Cetuximab and Bevacizumab].
O'hara H; Yamamoto H
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1669-1672. PubMed ID: 30449861
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
4. [Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report].
Tagami Y; Ogata S; Katakawa M; Bando Y
Gan To Kagaku Ryoho; 2012 Feb; 39(2):317-9. PubMed ID: 22333652
[TBL] [Abstract][Full Text] [Related]
5. [A case of remnant liver metastases after resection of liver metastases from rectal cancer following treatment with 5-FU, L-OHP and CPT-11, with markedly effective treatment by cetuximab plus S-1].
Takeuchi M; Ogata Y; Ishibashi N; Uchida S; Murakami N; Kibe S; Takahashi K; Yahara T; Shirouzu K
Gan To Kagaku Ryoho; 2012 May; 39(5):843-6. PubMed ID: 22584346
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Liver Metastasis from Colorectal Cancer That Showed a Pathological Complete Response to mFOLFOX6 plus Cetuximab].
Konishi K; Ikenaga M; Ohta K; Nakashima S; Nakagawa T; Endo S; Yamada T; Chihara T; Nishijima J
Gan To Kagaku Ryoho; 2016 Aug; 43(8):1003-7. PubMed ID: 27539045
[TBL] [Abstract][Full Text] [Related]
7. [A Case Report on a Successful Resection after FOLFIRI plus Cetuximab Therapy for Unresectable Colorectal Cancer with Multiple Liver Metastases].
Kanamori M; Kurumiya Y; Mizuno K; Sekoguchi E; Kobayashi S; Fukami Y; Kiriyama M; Aoyama H; Oiwa T; Miyamura K; Jinno T; Nakashima Y; Mori M
Gan To Kagaku Ryoho; 2017 May; 44(5):417-420. PubMed ID: 28536339
[TBL] [Abstract][Full Text] [Related]
8. [Experience of Ramucirumab plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer in Our Hospital].
Hagino S; Miyata T; Sakamoto K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1559-1561. PubMed ID: 29394701
[TBL] [Abstract][Full Text] [Related]
9. [A case of liver metastases from rectal cancer showed a complete response by FOLFIRI and bevacizumab chemotherapy].
Kuwada A; Nakamitsu A; Imamura Y; Kouyama M; Uekami S; Touge K; Taogoshi H; Fukuda Y; Daimaru H
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2937-40. PubMed ID: 21160275
[TBL] [Abstract][Full Text] [Related]
10. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment with cetuximab combination chemotherapy in a case of FOLFOX-refractory rectal cancer with previously unresectable multiple liver metastases leading to complete resection].
Mitsuhashi K; Matsusaka S; Mizunuma N; Ichimura T; Ozaka M; Ogura M; Shinozaki E; Suenaga M; Chin K; Fujimoto Y; Saiura A; Yamamoto N; Hatake K
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2203-7. PubMed ID: 21084828
[TBL] [Abstract][Full Text] [Related]
12. [Two Cases of Metastatic Rectal Cancer Patients Who Received Chemotherapy with FOLFOXIRI plus Bevacizumab].
Nishii T; Uchima Y; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Aomatsu N; Iwauchi T; Morimoto J; Nakazawa K; Tei S; Takeuchi K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1705-1707. PubMed ID: 28133105
[TBL] [Abstract][Full Text] [Related]
13. [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
Nishigami K; Kawami H; Yamaguchi T; Yamaguchi K; Kato S
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1765-8. PubMed ID: 19838045
[TBL] [Abstract][Full Text] [Related]
14. [A Patient with Recurrent Ulcerative Colitis-Associated Rectal Cancer Attaining a Complete Response with FOLFIRI plus Bevacizumab].
Iseki Y; Maeda K; Shibutani M; Nagahara H; Ikeya T; Tamura T; Ohira G; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Hirakawa K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2205-7. PubMed ID: 26805312
[TBL] [Abstract][Full Text] [Related]
15. [Safety and Efficacy of TAS-102 with Bevacizumab for the Treatment of Unresectable Metastatic Colorectal Cancer - A Case Report].
Arakawa S; Horiguchi A; Tomishige H; Kawabe N; Nagata H; Ishihara S; Ito M; Asano Y; Ito R; Isetani M; Shimizu K; Kamio K; Kawai T; Yasuoka H; Imaeda Y
Gan To Kagaku Ryoho; 2018 Apr; 45(4):649-651. PubMed ID: 29650823
[TBL] [Abstract][Full Text] [Related]
16. SPIRITT: A Randomized, Multicenter, Phase II Study of Panitumumab with FOLFIRI and Bevacizumab with FOLFIRI as Second-Line Treatment in Patients with Unresectable Wild Type KRAS Metastatic Colorectal Cancer.
Hecht JR; Cohn A; Dakhil S; Saleh M; Piperdi B; Cline-Burkhardt M; Tian Y; Go WY
Clin Colorectal Cancer; 2015 Jun; 14(2):72-80. PubMed ID: 25982297
[TBL] [Abstract][Full Text] [Related]
17. [A Case of an Unresectable Locally Advanced Rectal Cancer with Surrounding Organ Invasion Successfully Resected after Chemotherapy with mFOLFOX6 plus Cetuximab].
Takagi H; Ariake K; Takemura S; Doi T
Gan To Kagaku Ryoho; 2016 Mar; 43(3):377-9. PubMed ID: 27067860
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients].
Shioiri M; Hasegawa M; Tanaka H; Toura I; Kudo S; Sato K; Inoue K; Nakanishi T; Nishiyama S; Takebe S; Ogino Y; Ohsaki S; Nagashima Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2198-200. PubMed ID: 23268022
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Advanced Recurrent Rectal Cancer Successfully Treated by Rechallenge Therapy with an Anti-Epidermal Growth Factor Receptor(EGFR)Drug].
Sakuma T; Shibutani M; Fukuoka T; Kasashima H; Nishiyama M; Fukui Y; Natsuki S; Nishiyama T; Maruo K; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Maeda K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1504-1506. PubMed ID: 38303322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
